# Alzheimers NZ — 16 August 2024 submission to the aged-care neurological cognitive disorders inquiry

Document ID: doc-0129

Publisher/source: Alzheimers New Zealand

Physical PDF pages: 20

Catalogue document/version date: 2024-08-16

Original capture/access label: June 2026

Original and primary sources reviewed: 10 October 2026

[Preserved bundled original](/pdfs/2024%20-%20Alzheimers%20NZ%20-%20Submission%20to%20Health%20Select%20Committee.pdf)

[Primary publisher PDF](https://cdn.alzheimers.org.nz/wp-content/uploads/2024/08/Alzheimers-NZ-submission-to-Health-Select-Committe-Inquiry-to-Aged-Care-Sector-16-August.pdf)

[Publisher context page](https://alzheimers.org.nz/explore/advocacy/publications/)

## What the document contributes

Alzheimers NZ’s 20-page submission, dated 16 August 2024, argues for sustainable community dementia support and an integrated continuum of older-person care. It asks Government to fund and implement the 2020–2025 Dementia Mate Wareware Action Plan and establish multi-year, nationally consistent community contracts. It combines lived-experience accounts with historical prevalence estimates, funding comparisons and a joint business case. Its around-30,000 unmet-need estimate is modelled from a 2023 baseline and service assumptions, rather than a measured current waiting list. Funding requests and predicted benefits are advocacy proposals, not approvals, entitlements or proof of implementation.

## Included material

- Dated submission, key points and principal recommendations (physical pp. 1–4)
- Organisation, dementia background and historical projections (pp. 4–8)
- Care gaps, carers and integrated care (pp. 8–10)
- Historical community-service funding and proposed business case (pp. 11–14)
- Recommendations, equity, workforce, digitalisation and monitoring (pp. 15–17)
- Expected benefits, consequences of inaction and signed conclusion (pp. 18–20)

## Substantive findings

- The submission is dated 16 August 2024 and addresses the Health Committee inquiry into aged-care support for people experiencing neurological cognitive disorders; Catherine Hall signs as Chief Executive at the conclusion. (Physical pp. 1, 20.)

- Its three principal requests are funding and implementation of the 2020–2025 action plan, an integrated continuum of older-person health services, and multi-year nationally consistent contracts based on the joint Fair funding for community-based dementia services business case. (Physical pp. 3, 15.)

- The around-30,000 unmet-need claim uses an estimated 73,000 people with dementia in 2023, local-service and residential-care counts and an assumed private/pilot-service allowance. The 20% allowance’s denominator is not clearly stated; this is an organisational model, not a current service census or waiting list. (Physical pp. 2, 11.)

- The submission cites a 2023 joint business case for 17 community organisations, total funding of $11.8 million and 58% contributed through Health NZ contracts. These are historical submission/business-case figures, not a verified current national appropriation. (Physical pp. 11, 12.)

- Carer support, culturally appropriate access, respite, workforce sustainability, digital support and systematic indicators are proposed enablers. Their anticipated benefits are not evaluated implementation outcomes in this document. (Physical pp. 9, 10, 16, 17.)

- The submission acknowledges Budget 2022 governance and pilot funding despite broader no-action rhetoric elsewhere. Its case for further implementation should not be read as evidence that no dementia plan was ever endorsed or funded. (Physical pp. 3, 9.)

- The Health Committee subsequently announced a final inquiry report with 14 recommendations on 20 November 2025. This later primary publication does not establish Government acceptance or completed implementation of the submission’s requests. Source: [Health Committee release, 20 November 2025](https://www3.parliament.nz/en/pb/sc/committees-press-releases/health-committee-reports-findings-of-aged-care-inquiry-to-the-house/).

## Identity, dates and provenance

The correspondence date 16 August 2024 is printed on physical p. 1 and matches production metadata. The publisher lists an August 2024 submission. This is a document date, not independently established first public-release day or committee receipt date.

The original SHA-256 is 67afee291ea0d4c4d3eee49a86f57c17e31c1e8897e750b3c653c18ccb807445 (411,412 bytes); the live publisher-linked download was byte-identical when checked on 10 October 2026. The earlier Parliament homepage catalogue link was not this specific document’s publisher source. Original PDF, filename and June 2026 capture/access are retained. Review day, metadata production dates, document/version dates and subsequent publications are distinct.

## Practical use and implications

- Trace a stakeholder’s 2024 funding and contracting case, compare it with subsequent committee and sector publications, and seek separate decisions, budgets and outcome evidence before claiming implementation.

- Distinguish plan endorsement, funding allocations, pilots, proposed contract models and full implementation; use separate primary decisions and evaluations for each.

- The business case argues for longer contracts and integrated support, but its modelled costs and avoided-service benefits are not current reimbursement rates or guaranteed savings.

- Lived-experience accounts identify navigation and respite concerns without determining present eligibility or local availability. Seek current Health NZ and local support information for care needs.

## Historical and current context

The [publisher’s publications list](https://alzheimers.org.nz/explore/advocacy/publications/) identifies the August 2024 submission. The [Health Committee’s later release](https://www3.parliament.nz/en/pb/sc/committees-press-releases/health-committee-reports-findings-of-aged-care-inquiry-to-the-house/) records its final report on 20 November 2025; that report is distinct from this submission. Dementia NZ published its [successor 2026–2031 sector plan article](https://dementia.nz/dementia-mate-wareware-action-plan-2026-2031/) on 24 September 2025. The submission’s blanket no-treatment statement should not guide care: current [Health NZ](https://www.healthnz.govt.nz/health-topics/conditions-treatments/brain-and-nerves/dementia) and [WHO](https://www.who.int/news-room/fact-sheets/detail/dementia) guidance discuss symptom management and support.

## Evidence boundaries

Historical stakeholder submission and joint-business-case advocacy, not the final committee report or government approval. Original document date is 16 August 2024; receipt and first public-release day were not independently established. Prevalence, unmet need, contracts and cost figures reflect cited historical estimates and assumptions. The private/pilot allowance’s denominator is unclear. Broad no-action rhetoric is qualified by the submission’s own Budget 2022 pilot acknowledgement and the separate official plan-endorsement source. Its no-treatment statement is not current clinical guidance; current primary health sources discuss treatment and support. Later committee recommendations and a successor sector plan do not prove delivery. Original PDF, hash, filename and June capture/access are preserved; reviewed 10 October 2026.

The submission’s around-30,000 unmet-need estimate (physical p. 11 footnote 2) uses a 2023 estimated prevalence baseline, 9,300 local-service recipients, 26,000 people in residential care and a private/pilot allowance of 20% whose denominator is not clearly specified. It is not a measured current waiting list. Proposed per-day business-case costs and predicted savings are not an individual subsidy or reimbursement rate. Physical p. 3’s broad no-action wording sits alongside acknowledged Budget 2022 governance/pilot funding on p. 9; the [Ministry’s separate official page](https://www.health.govt.nz/information-releases/endorsement-of-improving-dementia-mate-wareware-services-in-aotearoa-new-zealand-action-plan) also records endorsement of the September 2021 sector plan. Endorsement, funding and complete implementation are different claims. Physical p. 5’s no-treatment statement should not be copied as current care advice; current WHO and Health NZ sources discuss symptom management and support.

## Primary context references

- [Primary source](https://alzheimers.org.nz/explore/advocacy/publications/)
- [Primary source](https://www3.parliament.nz/en/pb/sc/committees-press-releases/health-committee-reports-findings-of-aged-care-inquiry-to-the-house/)
- [Primary source](https://dementia.nz/dementia-mate-wareware-action-plan-2026-2031/)
- [Primary source](https://www.healthnz.govt.nz/health-topics/conditions-treatments/brain-and-nerves/dementia)
- [Primary source](https://www.who.int/news-room/fact-sheets/detail/dementia)

## Research evidence

Complete original page text, metadata, hashes, primary download equality, publisher links, current-context captures and source limits are preserved in artifacts/research/dementia-and-commissioner-source-audit-2026-10-10.json. The Ministry endorsement page was readable through the web tool; direct Python retrieval returned 403, so the fixture distinguishes the retained excerpt hash from unavailable HTML bytes.